Systematic Financial Management LP Vanda Pharmaceuticals Inc. Transaction History

Systematic Financial Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$9.32 - $12.02 $276,244 - $356,272	-29,640 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$9.66 - $12.02 $88,099 - $109,622	-9,120 Reduced 23.53%	29,640 $339,000
Q1 2020 May 12, 2020	BUY	$7.5 - $16.8 $22,912 - $51,324	3,055 Added 8.56%	38,760 $402,000
Q4 2019 Feb 14, 2020	SELL	$12.38 - $17.47 $81,584 - $115,127	-6,590 Reduced 15.58%	35,705 $586,000
Q3 2019 Nov 06, 2019	SELL	$12.27 - $15.79 $300,860 - $387,170	-24,520 Reduced 36.7%	42,295 $562,000
Q2 2019 Jul 26, 2019	BUY	$13.37 - $18.85 $893,316 - $1.26 Million	66,815 New	66,815 $941,000

154

43.4M

33.8K

28.7K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $265M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Systematic Financial Management LP, based on Form 13F filings with the SEC.

Stay updated on Systematic Financial Management LP with notifications on news.